The Australian Government has announced $35 million to advance research in type 1 (juvenile) diabetes over five years. Funding for the Special Research Initiative for Type 1 Juvenile Diabetes was announced yesterday by Minister for Education Christopher Pyne and Minister for Health Peter Dutton. [ + ]

US researchers believe they have answered the last major question in the effort to understand the pathway that leads to the creation of a bacterium’s cell wall. It is possible that their breakthrough could help lead to the wall's destruction and, with it, the eradication of various types of bacterial infection. [ + ]

Cells subjected to too much stress die, but if the stress isn't too extensive they engage an adaptive mechanism that helps them continue living. [ + ]

US research has found that while women are consistently attracted to studying biology in graduate school, numbers drop dramatically among faculty members. [ + ]

Expressions of interest are invited for a new training program that will arm early-career postgraduate researchers involved in medical technology and product-related research with the necessary entrepreneurial skills to successfully commercialise a medical technology. [ + ]

Fish can fly and a new book by Steve Howell reveals the strange beauty of these little-known creatures. [ + ]

Antisense Therapeutics has picked up a Canadian patent covering ATL1103 - a potential treatment for growth disorders including acromegaly - and has dosed 24 patients in a phase II trial. [ + ]

LBT Innovations (ASX:LBT) has published results from the largest study to date into the ability of its APAS technology to screen agar plates for potential pathogens. [ + ]

Deciphering how pain-relief drugs such as anaesthetics work on the body may lead to more targeted treatments for pain. [ + ]

The latest edition of AusBiotech's journal, Australasian Biotechnology (July 2014, Volume 24, Number 2), is out now. [ + ]

Sydney's NeuClone has entered a global partnership with The Serum Institute of India to produce a portfolio of 10 biosimilar monoclonal antibody drugs. [ + ]

German researchers have tested a new type of optical fibre with a hollow core, which is able to guide UV laser light without being damaged and with acceptable loss. Such light would normally damage conventional optical fibres. [ + ]

Imugene's (ASX:IMU) second-largest shareholder, small caps investor Otto Buttula, has taken a seat on the company's board. [ + ]

Analytica (ASX:ALT) has recruited the first group of Australian clinician referral partners for its controlled launch of urinary incontinence device therapy PeriCoach. [ + ]

New ARC funding has been allocated to map out strategic long-term plans for agricultural science, chemistry and the earth sciences. [ + ]